Simplifying Content To Drive Better Customer Experiences
Optimized Life Sciences Content Creation
With Omnipresence, no-code/low-code content development supports the creation of truly responsive content as well as rapid import of HTML, PowerPoint and PDF content. With an approval workflow, version control, comment tracking, compliant content can be managed with ease. Global and regional templating as well as smart change control reduce the burden on review committees and improves the speed of the release cycle to the field.
Life Sciences Low-Code, No-Code Content
Omnipresence provides field and medical teams with all the benefits of interactive presentations, supportive of animations and branching logic to help with ease navigation during conversation, without all the heavy agency costs and lengthy timelines.
Built in life sciences content elements such as an important safety information section, an interactive navigation carousel for slides, and tracking at page level or interactivity level in enhanced presentations.
Modern Digital Content for Life Sciences
An asset library with operation team level controls and segmentation by user type and brand
Smart Change Control
Smart change control allow different medical and legal groups to be triggered access at the right point in the workflow
Creation of content for all medium types such as email, detail aids, websites, and more
Ease of creation and responsive design is conducive to templating strategies both locally and globally and across deliverable types
53% of pharma CEOs are not satisfied with their digital implementation.The typical content development cycle is 8-10 weeks and that just doesn’t jive with modern life.
Watch the video to learn more about how we optimize content creation
Pfizer and Indegene Collaborate to Reimagine Medical Writing
At AI Summit 2019, Pfizer and Indegene discuss how content generated throughout the drug development lifecycle is managed using medically trained artificial intelligence to accelerate authoring and updating of clinical and regulatory documents.